Mortality of patients with parkinson's disease treated with levodopa R. J. MarttilaU. K. RinneV. Sonninen Original Investigations Pages: 147 - 153
The bioavailability of phenytoin R. GuglerW. FröscherG. Hildenbrand Original Investigations Pages: 155 - 162
Familial focal loss of cross striations G. K. van WijngaardenJ. BethlemJ. M. Gérard Original Investigations Pages: 163 - 172
Temperature dependence of normal sensory nerve action potentials H. P. LudinF. Beyeler Original Investigations Pages: 173 - 180
Changes of sensory conduction velocity and refractory periods with decreasing tissue temperature in man K. LowitzschH. C. HopfJ. Galland Original Investigations Pages: 181 - 188
A temporal study of survival of patients with pontine gliomas Mitsuhiro HaraKazuo Takeuchi Original Investigations Pages: 189 - 196
Biochemical findings in multiple sclerosis F. Gosseye-LissoirP. DelmotteH. Carton Original Investigations Pages: 197 - 205
Amyloid neuropathy due to monoclonal gammopathy B. NeundörferJ. G. MeyerB. Volk Original Investigations Pages: 207 - 215
Malignant diseases among patients with multiple sclerosis Jorma PaloJules DuchesneJuhani Wikström Original Investigations Pages: 217 - 222
Reversible spastic and pyramidal tract signs in a patient with parkinson's disease on L-Dopa Sepp SeyfertMax Straschill Short Communications Pages: 223 - 226